Preference for rizatriptan 10-mg wafer versus eletriptan 40-mg tablet for acute treatment of migraine

被引：0

作者：

Lainez, MJA

Evers, S

Kinge, E

Allais, G

Allen, C

Rao, NA

Rachid, M

Lis, K

机构：

[1] Univ Valencia, Hosp Clin, Valencia, Spain

[2] Univ Munster, D-4400 Munster, Germany

[3] Sanvika Neurol Serv, Sanvidka, Norway

[4] Univ Turin, I-10124 Turin, Italy

来源：

CEPHALALGIA | 2005年 / 25卷 / 10期

关键词：

rizatriptan wafer; eletriptan; patient preference;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：923 / 924

页数：2

共 50 条

[31] Head-to-Head, Open Label, Randomized, Prospective Short-Term Preventive Treatment Study of Menstrual Migraine with Eletriptan 40mg Versus Sumatriptan 50mg
Dolezil, David
NEUROLOGY, 2009, 72 (11) : A91 - A91
[32] Cost-effectiveness of eletriptan 40mg compared with standard doses of available triptans for acute migraine attacks in Spain
Gracia-Naya, M
Rejas, J
León, T
VALUE IN HEALTH, 2003, 6 (06) : 762 - 762
[33] REPERFUSION RATE AFTER INTRAVENOUS DOSE OF 40-MG VERSUS 80-MG PROUROKINASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - A COOPERATIVE STUDY
MATHEY, DG
SCHOFER, J
HAMM, C
BLEIFELD, W
ERBEL, R
DIEFENBACH, C
VONOLSHAUSEN, K
ZEITSCHRIFT FUR KARDIOLOGIE, 1987, 76 : 39 - 39
[34] Efficacy and tolerability of eletriptan through the clinical dose range vs. sumatriptan 100 mg for the acute treatment of migraine
Diener, HC
Mathew, N
Hettiarachchi, J
Sun, W
CEPHALALGIA, 2003, 23 (07) : 701 - 702
[35] Oral eletriptan versus subcutaneous sumatriptan: An open-label crossover study of patient preference in the acute treatment of migraine
Sikes, C.
Sun, W.
Hettiarachchi, J.
EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 238 - 238
[36] Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study
Salonen, R
Ashford, EA
Hassani, H
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, : 16 - 24
[37] Rizatriptan 5 mg for the acute treatment of migraine in adolescents: A randomized, double-blind, placebo-controlled study
Winner, P
Lewis, D
Visser, WH
Jiang, KH
Ahrens, S
Evans, JK
HEADACHE, 2002, 42 (01): : 49 - 55
[38] Zolmitriptan 2.5 mg orally disintegrating tablet for acute treatment of migraine: Part I, efficacy and tolerability
Dowson, AJ
Purdy, A
MacGregor, EA
NEUROLOGY, 2001, 56 (08) : A219 - A219
[39] A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers
Monif, Tausif
Thudi, Nageshwar Rao
Tippabhotla, Sudhakar Koundinya
Khuroo, Arshad
Marwah, Amit
Shrivastav, Vikesh Kumar
Tandon, Monika
Raghuvanshi, Rajeev
Biswal, Shibadas
CLINICAL THERAPEUTICS, 2007, 29 (12) : 2677 - 2684
[40] Comparison of oral eletriptan (40-80 mg) and oral sumatriptan (50-100 mg) for the treatment of acute migraine: a randomised, placebo-controlled trial in sumatriptan-naive patients.
Pryse-Phillips, W
CEPHALALGIA, 1999, 19 (04) : 355 - 356

← 1 2 3 4 5 →